Clinical Trial Update: The Safety and Tolerability Study With ER2001 Intravenous Injection in Adults With Early Manifest Huntington's Disease [EARLY_Phase 1]

View source ↗

Summary

Safety and tolerability results are reported for a Phase 1 intravenous study of ER2001 in adults with early manifest Huntington's disease; the trial has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Huntington Disease

Drugs mentioned

• ER2001

Snippet

Sponsor: ExoRNA Bioscience | Conditions: Huntington Disease | EARLY_Phase 1 | Status: COMPLETED